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Abstract: Carpal Tunnel Syndrome (CTS) remains a puzzling and disabling condition present in 3.8% of the general 
population. CTS is the most well-known and frequent form of median nerve entrapment, and accounts for 90% of all 
entrapment neuropathies. This review aims to provide an overview of this common condition, with an emphasis on the 
pathophysiology involved in CTS. The clinical presentation and risk factors associated with CTS are discussed in this 
paper. Also, the various methods of diagnosis are explored; including nerve conduction studies, ultrasound, and magnetic 
resonance imaging. 
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WHAT IS CARPAL TUNNEL SYNDROME? 
  First described by Paget in 1854 [1], Carpal Tunnel 
Syndrome (CTS) remains a puzzling and disabling condition 
commonly presented to Rheumatologists and Orthopaedic 
Hand clinicians. It is a compressive neuropathy, which is 
defined as a mononeuropathy or radiculopathy caused by 
mechanical distortion produced by a compressive force [2]. 
The American Academy of Orthopaedic Surgeons (AAOS) 
Clinical Guidelines on the Diagnosis of CTS defines it as a 
symptomatic compression neuropathy of the median nerve at 
the level of the wrist [3]. 
  CTS is the most well-known and frequent form of 
median nerve entrapment [3-8], and accounts for 90% of all 
entrapment neuropathies [9]. An entrapment neuropathy is a 
chronic focal compressive neuropathy caused by a pressure 
increase inside non-flexible anatomical structures [10]. CTS 
is a neuropathy caused by entrapment of the median nerve at 
the level of the carpal tunnel, delimitated by the carpal bones 
and by the transverse carpal ligament [2]. Physiological 
evidence indicates increased pressure within the carpal 
tunnel, and therefore decreased function of the median nerve 
at that level [3]. 
  Other forms of median nerve entrapment neuropathies 
include pronator syndrome and anterior interosseous nerve 
syndrome. Pronator syndrome is defined as compression of the 
median nerve in the forearm that results in sensory alteration in 
the median nerve distribution of the hand and the palmar 
cutaneous distribution of the thenar eminence [11, 12]. 
Anterior interosseous nerve syndrome [13] is characterised by 
complete or partial loss of motor function of the muscles 
innervated by the anterior interosseous nerve (AIN), a motor 
branch of the median nerve in the forearm [4]. 
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EPIDEMIOLOGY 
  CTS is the most frequent entrapment neuropathy [2], 
believed to be present in 3.8% of the general population [14]. 1 
in every 5 subjects who complains of symptoms such as pain, 
numbness and a tingling sensation in the hands is expected to 
have CTS based on clinical examination and electrophysio-
logical testing [4], idiopathic CTS being the most common 
diagnosis in patients with these symptoms [15]. 
  Incidence rates of up to 276:100,000 per year have been 
reported [16], with a prevalence rate up to 9.2% in women and 
6% in men [13]. More common in females than in males, its 
occurrence is commonly bilaterally with a peak age range of 40 
to 60 years [17]; although it occurs in all age groups. The 
prevalence of CTS in the United Kingdome (UK) alone is 7-
16% [9]); much higher than the 5% prevalence in the United 
States (US) [3]. 
  In all western countries, an increase is reported in the 
number of work-related musculoskeletal disorders (WMSDs) 
caused by strain and repeated movements (biomechanical 
overload). In Europe, in 1998, over 60% of upper limb 
musculoskeletal disorders recognised as work-related were CTS 
cases cases [18,19]. Some industries such as fish processing 
have reported the prevalence of CTS in their workers to be as 
high as 73% [20]. 
  This data may reflect the increasing level of sensitivity to 
this problem, which is translated into a higher number of 
reports, rather than reflecting an actual increase in the 
prevalence of CTS [2]. There certainly has been an increase 
in the number of CTS patients, but this could be due to the 
general increase in the life span of people and the increased 
number of diabetic patients [21]. Diabetic patients have a 
prevalence rate of 14% and 30% without and with diabetic 
neuropathy, respectively [22], whilst the prevalence of CTS 
during pregnancy has been reported to be around 2% [23]. 
SOCIOECONOMIC EFFECTS 
  Median number of days away from work due to CTS is 
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1995, 400,000-500,000 patients underwent surgical 
decompression, which equates to an economic cost of in 
excess of $2 billion [9], whilst UK surgical decompression 
rate is 43-74 per 100,000 [9]. This amounts to a heavy 
burden on the National Health Service to provide care for 
CTS patients in the form of clinicians’ time, diagnosis, and 
conservative management and treatment options. 
CLINICAL PRESENTATION 
  Primary features of CTS include pain in the hand, 
unpleasant tingling, pain or numbness in the distal 
distribution of the median nerve (thumb, index, middle 
finger and the radial side of the ring finger) [25]), and a 
reduction of the grip strength and function of the affected 
hand [26]. Symptoms tend to be worse at night, and 
clumsiness is reported during the day with activities 
requiring wrist flexion [27]). Patients often describe a 
phenomenon termed the “flick sign”, in which shaking or 
flicking their wrists relieves symptoms [28]. 
  Many patients report symptoms outside the distribution 
of the median nerve as well, which has been confirmed by a 
systematic study conducted by Stevens et al., [29]. In 159 
hands of patients with electrodiagnostically confirmed CTS, 
symptoms were most commonly reported in both the median 
and ulnar digits more frequently than the median digits 
alone. They also report location of symptoms in areas other 
than the digits. 21% of patients had forearm paraesthesias 
and pain; 13.8% reported elbow pain; 7.5% reported arm 
pain; 6.3% reported shoulder pain; and 0.6% reported neck 
pain [29]. Interestingly, trigger digit presentation 
accompanies idiopathic CTS in approximately 20% of 
patients [30]. 
  A large multicentre study has confirmed that patients 
with mild to moderate CTS are more likely to report 
substantial symptoms and mild functional limitations, 
whereas patients with more severe disease may report less 
severe symptoms, but have more severe functional 
limitations of the hand [31]. This appears to be a 
contradiction, but in fact it relates to the fact that severe 
compromise of the median nerve may impair sensory 
functioning to the extent that the profound numbness 
minimizes the experience of tingling and pain. However, 
profound functional limitations will ensue as a result of such 
a level of numbness and motor impairment [32]. 
  Patients suffering from CTS often report subjective 
feelings of swelling in their hands or wrists, but no apparent 
swelling can be observed. However, some clinicians find that 
this symptom has some diagnostic value attached to it [33]. 
In study of over 8000 patients with suspected CTS, 
symptoms on the radial part of the hand and nocturnal 
exacerbation of symptoms were most strongly predictive of 
positive NCS [34]. In a retrospective study of 1039 patients 
with a neurophysiological diagnosis of CTS, Nora et al., [35] 
found that the most characteristic manifestation of the 
syndrome was parasthesia in the median nerve distribution, 
frequently extending to the whole hand. Pain was very 
common but less specific, and weakness was rare [35]. 
  Phalen noted a volar wrist swelling in several patients - a 
visual and palpable swelling into the shape of a “hot dog”. 
He studied this presentation in 82 hands with CTS and in 
200 control hands, and found that it correlated well with 
Tinel and Phalen signs. He concluded that it is a useful 
diagnostic sign, because it depends on clinical observation 
rather than the patient’s history [36]. 
CTS may be classified on the basis of symptoms and signs into three 
stages: 
 
Stage 1: Patients have frequent awakenings during the night with a 
sensation of a swollen, numb hand. They report severe pain that 
irradiates from the wrist to the shoulder, and an annoying tingling in 
their hand and fingers (brachialgia paraesthetica nocturna). Hand 
shaking (the flick sign) relives the symptoms. During the morning, a 
sensation of hand stiffness usually persists. 
 
Stage 2: The symptoms are present also during the day, mostly when the 
patient remains in the same position for a long time, or performs 
repeated movements with their hand and wrist. When motor deficit 
appears, the patient reports that objects often fall from his/her hands 
because they are unable to feel their fingers anymore. 
 
Stage 3: This is the final stage in which atrophy (wasting) of the thenar 
eminence is evident, and the median nerve usually responds poorly to 
surgical decompression [4]. In this phase, sensory symptoms may 
diminish [6].  There is also aching in the thenar eminence, and with 
severe compression, weakness and atrophy of the abductor pollicis 
brevis and opponens pollicis [7, 8]. 
 
  Some patients may present with atypical signs of CTS, 
such as “writer’s cramp” or fatigue, pain in the shoulder only 
[37], cold sensitivity in the fingers (presumably reflecting 
the median nerve’s supply of sympathetic fibres to part of 
the forearm and hand), forearm pain [38], or numbness in the 
third finger only [27]. Sometimes there may be no symptoms 
but patients present with visual thenar atrophy and 
denervation on nerve conduction studies [27]. 
  In some instances, patients only have symptoms with 
rigorous activity, usually work-related, and present with 
minimal symptoms or objective findings when examined. 
This is termed “dynamic CTS” and patients usually benefit 
from conservative management, including alteration of work 
duties. Therefore, the importance of a well-defined history is 
particularly important in these cases [39]. 
ANATOMY 
  The carpal tunnel is composed of a bony canal, 
consisting of carpal bones, the roof of which is the fibrous 
but rigid transverse carpal ligament. The carpal tunnel 
contains the nine flexor tendons and the median [27], which 
enters the tunnel in the midline or slightly radial to it [32]. 
Atypical presentations could be explained by anatomical 
variations in the median nerve itself [32]. 
  Sensory branches from the median nerve supply the 3 
radial digits and the radial half fourth digit - hence why CTS 
symptoms are felt in these fingers. The palmar sensory 
cutaneous branch of the median nerve supplies the cutaneous 
skin of the palm, and arises, on average, 6 cm proximal to 
the transverse carpal ligament (TLC). Therefore, the palm is 
generally not affected in CTS [27]. 
RISK FACTORS ASSOCIATED WITH CTS 
  CTS remains an idiopathic syndrome, but there are 
certain risk factors that have been associated with this 
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risk factors. Prolonged postures in extremes of wrist flexion 
or extension, repetitive use of the flexor muscles, and 
exposure to vibration are the primary exposures that have 
been reported [40-43]. 
  Medical risk factors can be divided into four categories: 
(1) extrinsic factors that increase the volume within the 
tunnel (outside or inside the nerve); (2) intrinsic factors 
within the nerve that increase the volume within the tunnel; 
(3) extrinsic factors that alter the contour of the tunnel; and 
(4) neuropathic factors. 
  Extrinsic factors that can increase the volume within the 
tunnel include conditions that alter the fluid balance in the 
body. These include pregnancy, menopause, obesity, renal 
failure, hypothyroidism, the use of oral contraceptives and 
congestive heart failure [32]. 
  Intrinsic factors within the nerve that increase the 
occupied volume inside the tunnel include tumours and 
tumour-like lesions. Extrinsic factors that can alter the 
contour of the tunnel could be the aftermath of fractures of 
the distal radius, directly or via posttraumatic arthritis [32]. 
  Neuropathic factors, such as diabetes, alcoholism, 
vitamin toxicity or deficiency, and exposure to toxins, can 
play a role in eliciting CTS symptoms. This is because they 
affect the median nerve without necessarily increasing the 
interstitial pressure within the carpal tunnel [32]. In fact, 
diabetic patients have higher tendency to develop CTS due 
to lower threshold for nerve damage [4]. 
PATHOPHYSIOLOGY 
  The pathophysiology of CTS involves a combination of 
mechanical trauma, increased pressure and ischemic injury 
to the median nerve within the carpal tunnel [44]. 
Increased Pressure 
  There are many pressure related studies of the carpal 
tunnel in humans [45-47]. Normal pressure has been 
recorded to be in the range of 2-10 mm Hg [4]. There are 
dramatic changes of fluid pressure in the carpal tunnel with 
wrist position; extension increases the pressure 10-fold and 
wrist flexion increases it 8-fold [44]. Therefore, repetitive 
hand movements have been implicated as one of many risk 
factors for CTS. Experimental studies have suggested a 
dose-response curve - the greater the duration and amount of 
pressure, the more significant is the neural dysfunction [48]. 
Nerve Injury 
  An important step in injury to the median nerve is 
demyelination, which occurs when the nerve is repetitively 
subjected to mechanical forces [2]. Pressures much higher 
than systolic are necessary to produce focal demyelination 
[4]. Demyelination of the nerve develops in the compression 
site, and can then spread to the entire internodal segment, 
leaving the axons intact. A block of nervous transmission 
ensues (neuroapraxia). If the compression persists, bloodﬂow 
to the endoneural capillary system may be interrupted, 
leading to alterations in the blood-nerve barrier, and 
development of endoneural oedema. This starts a vicious 
cycle consisting of venous congestion, ischaemia and local 
metabolic alterations [2]. Axonal degeneration, macrophage 
attraction and activation, release of inﬂammatory cytokines, 
nitric oxide, and development of “chemical neuritis” are all 
consequences of this viscous cycle if it continues for a 
substantial amount of time [10]. 
Nerve Tethering 
  Nerve fibres have layers of connective tissue: the 
mesoneurium, epineurium, perineurium and endoneurium; 
which is the most intimate layer. The extensibility of these 
layers is critical to nerve gliding, which is necessary to 
accommodate joint motion; otherwise nerves are stretched 
and become injured [49]. 
  The median nerve will move up to 9.6 mm with wrist 
flexion and slightly less with extension [50]. Chronic 
compression results in fibrosis, which inhibits nerve gliding, 
leading to injury and therefore scarring of the mesoneurium. 
This causes the nerve to adhere to the surrounding tissue, 
resulting in traction of the nerve during movement as the 
nerve attempts to glide from this fixed position [32]. This is 
the basis of the tethered median nerve stress test (TMNST), 
which is can be used to diagnose chronic low-grade CTS 
[51]. 
Ischemic Injury 
  Ischemic injury has been identified as an essential 
component in CTS due to Gelberman et al.’s  observation 
that symptoms rapidly resolve after carpal tunnel release 
surgery [45]. Lundbrog et al., demonstrated that limb 
ischaemia increases paraesthesias in carpal tunnel patients 
[52]. Ischemic injury in CTS has three stages: (1) increased 
intrafunicular pressure; (2) capillary damage with leakage 
and oedema, and (3) obstruction of arterial flow [44]. 
Breakdown in the Blood-Nerve-Barrier 
  The blood-nerve-barrier formed by the inner cells of the 
perineurium and the endothelial cells of endoneurial 
capillaries that accompany the median nerve through the 
carpal tunnel. These endoneurial microvessels are formed 
from nutrient branches that arise from the radial and ulnar 
arteries, proximal to the flexor retinaculum [32]. An increase 
in pressure within the tunnel can cause a breakdown of 
vasculature within this barrier, causing an accumulation of 
proteins and inflammatory cells [32]. This may induce a 
miniature closed compartment syndrome by increasing the 
permeability, contributing to increased endoneurial fluid 
pressure and development of an intra-fascicular oedema [53]. 
Patients with vascular problems or prolonged exposure to 
static loading are particularly prone to a breakdown in the 
blood-nerve-barrier [32]. 
Synovial Tissue 
  Abnormalities of the synovial tissue lining the tendons 
within the carpal tunnel have been implicated as a closely 
related factor to the development of idiopathic CTS. This has 
been confirmed by MRI, histological and biochemical 
studies [54,55]. Abnormalities include thickening of the 
synovial tissue, which may be caused by repetitive hand 
activity [47-56]. This increases the volume of tissue within 
the canal, leading to an increase in the fluid pressure within 
the carpal tunnel [47]. The most profound thickening of 
synovial tissue has been reported to be at the entrance and 
exit regions of the canal where the tendons slide over a 
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damage to the synovial tissue as well as the median nerve 
can occur due to the different degrees of excursion between 
the flexor tendons and the median nerve [55-57]. 
As a result, biochemical changes in the synovial tissue 
ensue. For example, repetitive exposure of the tendons to 
compression or tensile strength can increase the proteoglycan 
content in the tendon matrix. Hypertrophy of the tendon 
occurs, increasing the cross-sectional area, which then in 
turn increases the pressure within the carpal tunnel [58,59]. 
Inflammation 
  Tenosynovitis, inflammation of the synovial tissue of the 
flexor tendons, can also cause increased pressure in the 
carpal tunnel and result in CTS [60]. This has been 
confirmed by the presence of increased expression of 
prostaglandin E2 and vascular endothelial growth factor 
(VEGF) in synovial biopsy tissue from patients with 
symptomatic CTS [61]. In response to this injury, there is an 
increase in fibroblast density, collagen fibre size, vascular 
proliferation, and type III collagen in the synovial connective 
tissue [62]. Constrictive scar tissue is formed around the 
median nerve [63], which in turn can result in tethering of 
the nerve. 
Involvement of Small Fibres 
  Most studies on compression and nerve function focus on 
the large myelinated nerves. However, the involvement of 
small fibres is very relevant and may help us understand the 
diversity of symptoms, such as the pain experienced by some 
patients in the distribution area of the median nerve [44]. 
This pain is caused by an abnormal diffusion of the Na+ 
channels into the damaged nociceptive ﬁbres, which are 
small C-fibres, resulting in hyperexcitability and ectopic 
discharge induction. Inﬂammatory mediators, in particular 
TNFa, play an important role in the pain-related symptoms 
of CTS [10]. 
DIAGNOSIS 
  Two papers by the Quality Standards Subcommittee of 
the American Academy of Neurology [64] and American 
Association of Electrodiagnostic Medicine, American 
Academy of Neurology and American Academy of Physical 
Medicine and Rehabilitation define the guidelines for 
clinical and neurophysiologic diagnosis of CTS [65]. These 
papers stress the importance of a thorough case history, 
which must focus on the following [2]: 
•  symptom onset - which in the early stage is mainly 
nocturnal paraesthesias. 
•  provocative factors - such as hand positions and 
repeated movements. 
•  working activity - instrument use, vibrating tools. 
•  pain localisation and irradiation - in the cutaneous 
median nerve region with ascending, sometimes up to 
the shoulder, or descending irradiation. 
•  manoeuvres which alleviate symptoms - e.g. hand 
shaking, position changes. 
•  presence of predisposing factors - e.g. diabetes, 
adiposity, chronic polyarthritis, myxoedema, 
acromegaly, pregnancy. 
•  sports activity - e.g. baseball, body-building. 
  The two provocative test most commonly used in the 
clinical setting are Phalen’s and Tinel’s tests. In Phalen’s 
test, the patient is asked to flex their wrist and keep it in that 
position for 60 seconds. A positive response is if it leads to 
pain or paraesthesia in the distribution of the median nerve 
[60]. The sensitivity of Phalen’s test is in the range of 67% 
to 83%, whilst the specificity ranges between 40% and 98% 
[66-68].  
Tinel’s test is performed by tapping over the volar surface of 
the wrist. A positive response is if this causes paraesthesia in 
the fingers innervated by the median nerve: the thumb, 
index, middle finger and the radial side of the ring finger [6]. 
Tinel’s test has a sensitivity in the range of 48% to 73%, 
whilst the specificity is 30% to 94% [66-68]. 
  It is evident that there are significant variations in these 
values, which may be attributed to the fact that there are 
substantial inconsistencies in the method of examination and 
interpretation of the results [15]. Therefore, some researchers 
have questioned their diagnostic value [69]. This, coupled 
with the fact that both Phalen’s and Tinel’s tests have a low 
positive predictive value, supports the view that such 
provocative tests are insufficient and unreliable when used 
alone in the diagnosis of CTS. This emphasises the 
importance of considering them with a good clinical history 
and other appropriate methods of examination, such as nerve 
conduction studies (NCS) [70]. This view has recently been 
supported by a study conducted by EL Miedany et al. [71]. 
They found that both Phalen’s and Tinel’s tests were in fact 
more sensitive and specific for the diagnosis of tenosynovitis 
than for the diagnosis of CTS. Therefore, they concluded 
that there is a greater reliance on NCS as a diagnostic gold 
standard in the diagnosis of CTS [72], despite the fact that 
false positives and negatives are known to exist [34]. 
  Although NCS can be regarded as a gold standard in the 
diagnosis of CTS, it is not a widely accepted and recognised 
phenomenon. This gives rise to problems in evaluating 
whether any individual test is accurate in diagnosing CTS, 
because there isn’t an accepted “gold standard” against 
which other tests can be compared [34,73]. These tests 
include the Diagnostic CTS Scale [74], the Symptom 
Severity Scale (SSS) and Functional Scale (FS) [75], the 
Katz hand diagram [39], and the Hand elevation test [76]. 
Differential Diagnosis [2]  
CTS must be differentiated from: 
•  Cervical radiculopathy (especially C6-C7) 
•  Brachial plexopathy (in particular of the upper trunk) 
•  Proximal median neuropathy (especially at the pronator teres level) 
•  Thoracic outlet syndrome 
•  CNS disorders (multiple sclerosis, small cerebral infarction) 
DIAGNOSIS: NERVE CONDUCTION STUDIES 
  Nerve Conduction Studies (NCS) have been developed as 
a result of the discovery in 1956 that median nerve 
conduction times are slowed across the wrists of hands in 
CTS patients [77]. Prolonged motor and sensory latencies of 
the median nerve, and reduced sensory and motor 
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CTS [78]. Even so, some authors have recently reported that 
optimal diagnostic criteria still remain uncertain [79]. 
The aims of NCS [3]  
(1) to conﬁrm a focal damage to the median nerve inside the carpal 
tunnel 
(2)  to quantify the neurophysiological severity by using a scale 
(3) to  deﬁne the nerve pathophysiology: conduction block, 
demyelination or axonal degeneration 
 
  NCS is considered to be the gold standard in the 
diagnosis of CTS because it is an objective test that provides 
information on the physiological health of the median nerve 
across the carpal tunnel. The standard method of diagnosis is 
comparing the latency and amplitude of a median nerve 
segment across the carpal tunnel to another nerve segment 
that does not go through the carpal tunnel, such as the radial 
or unlar nerve. The nerve is stimulated by a transcutaneous 
pulse of electricity, which induces an action potential in the 
nerve. A recording electrode, placed either distally or 
proximally, detects the wave of depolarization as it passes by 
the surface electrode [44]. 
  It is more accurate to compare the median nerve response 
to another nerve segment that does not travel through the 
carpal tunnel, as opposed to using ‘normal’ values for the 
amplitude and latency of individual nerves. This is because 
there are many factors that may influence the amplitude and 
latency of an individual nerve, giving a false positive or false 
negative result. Such factors include age, gender, finger 
diameter, concurrent systemic disease, obesity and 
temperature [80-82]. The use of a relative comparison of two 
nerve segments controls these factors. This is the most 
sensitive and accurate technique, with a sensitivity of 80- 
92% and specificity of 80-99% [44]. The study of motor 
conduction velocity and of distal motor latency (DML) in the 
median and ulnar nerves in the same hand may provide 
additional data [65]. 
  However, false negative and false positives can still 
occur [83,84] possibly due to lack of a standardised 
diagnostic criteria, resulting in 16-34% of clinically defined 
CTS being missed with NCS [85]. Moreover, blanket 
referrals for NCS are an expensive and inefficient approach 
to the diagnosis of CTS [86]. Another important issue to 
consider is the fact that many studies have reported that NCS 
does not change the probability of diagnosing CTS, 
emphasising importance of clinical history and examination 
[72]. 
Nerve Conduction Analysis [3] 
The electrophysiological classiﬁcation [5], in agreement with the AAEM 
guidelines, follows the neurophysiological progression of CTS severity 
and includes the following classes: 
Negative CTS: Normal ﬁndings on all tests (including comparative and 
segmental studies) 
Minimal CTS: Abnormal ﬁndings only on comparative or segmental 
tests 
Mild CTS: SCV slowed in the ﬁnger-wrist tract with normal DML 
Moderate CTS: SCV slowed in the ﬁnger-wrist tract with increased 
DML 
Severe CTS: Absence of sensory response in the ﬁnger-wrist tract with 
increased DML 
Extreme CTS: Absence of thenar motor response 
DIAGNOSIS: OTHER NEUROPHYSIOLOGIC 
EVALUATIONS 
  There are several types of clinical neurophysiologic 
evaluations of the median nerve across the wrist. These 
include vibrometry threshold testing, current perception 
testing, symptom questionnaire (hand diagrams), and other 
quantitative sensory testing (Semmes-Weinstein monofila-
ment testing, tactile sensation and two-point discrimination. 
These techniques are not as sensitive as NCS because they 
have considerable subjective components [44]. 
DIAGNOSIS: ULTRASOUND 
  The use of ultrasound (US) has been implicated in the 
diagnosis of CTS because thickening of the median nerve, 
flattening of the nerve within the tunnel and bowing of the 
flexor retinaculum are all features diagnostic of CTS [87]. 
Several studies have concluded that cross sectional area is 
the most predictive measurement, but there is debate 
regarding the level within the tunnel that this measurement 
should be taken, and what constitutes abnormal values [88-
90]. The cross-sectional area of the median nerve has been 
used in US to classify the severity of CTS as normal, mild, 
moderate and severe [91]. 
  A recent prospective study comparing the diagnostic 
utility of US versus EDS found that the two techniques had 
almost equal sensitivities. Sensitivities for EDS and US were 
67.1% and 64.7%, respectively. Interestingly, when EDS and 
US were used together the sensitivity increased to 76.5%, 
suggesting a role for US as a diagnostic adjunct to EDS. 
However, a significant flaw is that 23.5% of patients with 
clinically diagnosed CTS remained undetected [92]. 
DIAGNOSIS: MAGNETIC RESONANCE IMAGING 
  Magnetic Resonance Imaging (MRI) is excellent for 
picking up rare pathological causes of CTS such as ganglion, 
haemangioma or bony deformity - the presence of which 
may alter surgical intervention [93]. Furthermore, sagittal 
images are useful in showing the site accurately and allow 
the determination of the severity of nerve compression; with 
a sensitivity of 96%. However, specificity is extremely low 
at 33-38% [94]. 
  Swelling of the median nerve and increased signal 
intensity on T2-weighted images [95, 96] indicating 
accumulation of the axonal transportation, myelin sheath 
degeneration or oedema [97] are the signs to look out for 
when diagnosing CTS. 
  MRI is able to predict those patients who would benefit 
from surgical intervention, because the length of the 
abnormal nerve signal on T2-weighted MRI and the median-
ulnar sensory latency difference are good predictors of 
surgical outcome [98]. However, the results do not correlate 
well with patients’ perceived severity of symptoms [98], 
mainly because MRI provides anatomical information as 
opposed to information on nerve impairment and function. 
  Nevertheless, MRI is preferred by patients. Jarvik et al., 
reported that 76% of their patients found EDS to be 
unpleasant, whilst only 21% said the same about MRI [98]. 
On the other hand, it is an expensive procedure, and is 
therefore not routinely used. It is commonly used in 
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Carpal Tunnel Release (CTR), for differential diagnosis in the 
case of ambiguous symptoms and to confirm the presence of 
space-occupying lesions [15]. 
TREATMENT 
  The treatment of CTS falls under two categories: 
conservative and surgical. Conservative treatment is generally 
offered to patients suffering from mild to moderate symptoms 
of CTS [24]. Options of such treatment include oral and 
transvenous steroids, corticosteroids, vitamins B6 and B12 [99], 
nonsteroidal anti-inflammatory drug (NSAIDs), ultrasound, 
yoga, carpal bone mobilisation and the use of hand splints. 
O’Connor et al., reported that patients experienced significant 
short term benefits with this method of treatment, but have 
concluded that their efficacy in the long term remains unclear. 
Other conservative treatment options such as magnet therapy, 
exercise or chiropractic treatment did not show any significant 
improvement in symptoms when compared to a placebo or 
control [100]. 
  The use of steroid injections has been under significant 
scrutiny in research focusing on the conservative treatment of 
CTS [24]. A recent systematic review by Marshall et al., [39]) 
reported that steroid injections given to patients with clinical 
CTS produced a greater clinical improvement in symptoms one 
month after the injection compared to a placebo. On the other 
hand, they were unable to show any significant symptom relief 
beyond one month [101]. 
 Corticosteroid treatment is effective in reducing 
inflammation and oedema, but there are possible side effects 
that have to be considered when prescribing them to CTS 
patients. The main side effect is that it limits reduces collagen 
and proetoglycan synthesis, thus limiting tenocytes and hereby 
reducing the mechanical strength of the tendon. This leads to 
further degeneration [102-105]. 
  Surgical treatment of CTS is in the form of a carpal tunnel 
release (CTR); a procedure in which the transverse carpal 
ligament (TCL) is cut to increase the space in the carpal tunnel 
and hence reduce the interstitial pressure. Approximately 70-
90% of patients have good to excellent long-term outcomes 
following CTR [106]. 
  CTR remains an interesting option for diabetic patients with 
CTS as well as peripheral neuropathy. In these patients, 
symptoms would not be expected to be totally relived by CTR 
since some of their symptoms reflect non-entrapment 
mechanisms [107]. 
CONCLUSION 
  CTS remains one of the most well-known and frequent form 
of median nerve entrapment, and accounts for 90% of all 
entrapment neuropathies. This review of the recent literature has 
provided an overview of this common condition, with an 
emphasis on the pathophysiology and its relevance to the 
various methods of diagnosis including nerve conduction 
studies, ultrasound, and magnetic resonance imaging. 
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